ESR1 and breast cancer: Furthermore, linc-RoR can promote estrogen-independent growth of estrogen receptor (ER)-positive breast cancer by activating ERK, which in turn phosphorylates ERs at Ser118, promoting the ligand-independent activation of ERs [82].